# Boehringer Ingelheim Venture Fund: portfolio, investments and team

> Boehringer Ingelheim Venture Fund is a corporate vc based in Germany. 59 investments on record, 6 in the last 12 months, latest Sept 2026.

Source: https://millionrounds.com/fund/boehringer-ingelheim-venture-fund (Millionrounds; every figure on the page links to its filing or article)

Germany · [Investor](https://millionrounds.com/investors)

# Boehringer Ingelheim Venture Fund

Last cheque observed Sep 2026; 59 cheques on record.

Email

Deploying now Corporate VC

Pre-seed Seed Series A Cell Therapy Medicine Life-science

Follow Boehringer Ingelheim Venture Fund and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fboehringer-ingelheim-venture-fund)

Deploying now

**60%** of best year **6** **cheques in 12 months**, 59 on record

Since the last cheque **53** days **00** hrs **00** min **00** sec

Median round **$20M** Rounds led **5 of 59** Sole investor **7 rounds** Exits **1 from the portfolio** Mostly in **Germany, 34%**

Pitch Boehringer Ingelheim Venture Fund

## Boehringer Ingelheim Venture Fund highlights

- 01 6 cheques in the last 12 months
- 02 Mostly Series A and Seed: 55% of its rounds
- 03 Sole investor in 7 rounds, median $10M
- 04 1 exits from the portfolio

## What they do

- **Type:** Corporate VC (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Pre-seed Seed Series A Series B Growth
- **Sectors:** Cell Therapy Medicine Life-science
- **Based in:** Ingelheim Am Rhein, Germany
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **59 appearances**

- **2026** 6 rounds
- **Sept** **[Cloverleaf Bio](https://millionrounds.com/company/cloverleaf-bio)** Seed · 4BIO Capital **$33M** With 4 others
- **Jun** **[smartbax](https://millionrounds.com/company/smartbax)** Venture · DE **Undisclosed** With 1 other
- **Apr** **[Tacalyx](https://millionrounds.com/company/tacalyx)** Seed · DE **$13M** With 3 others
- **Feb** **[Centauri Therapeutics](https://millionrounds.com/company/centauri-therapeutics)** Series A · GB **$8.1M** With 2 others
- **Jan** **[TECregen](https://millionrounds.com/company/tecregen)** Seed · CH · Ventureburn **$13M** *Led*
- **Jan** **[STRM.BIO](https://millionrounds.com/company/strm-bio)** Seed · US **$8.0M** Sole investor
- **2025** 8 rounds
- **Oct** **[smartbax](https://millionrounds.com/company/smartbax)** Seed · DE **$5.5M** With 1 other
- **Aug** **[Wellth](https://millionrounds.com/company/wellth)** Series C · US · Comcast Ventures **$36M** With 8 others
- **Jul** **[EvlaBio](https://millionrounds.com/company/evlabio)** Seed · CH **$25M** With 1 other
- **Jun** **[ArrePath](https://millionrounds.com/company/arrepath)** Venture · US **Undisclosed** With 1 other
- **May** **[Nuevocor](https://millionrounds.com/company/nuevocor)** Series B · SG **$45M** With 3 others
- **Apr** **[HepaRegeniX](https://millionrounds.com/company/heparegenix)** Venture · DE **$24M** With 2 others
- **Mar** **[Brainomix](https://millionrounds.com/company/brainomix)** Series C · GB **$18M** With 4 others
- **Jan** **[Glox Therapeutics](https://millionrounds.com/company/glox-therapeutics)** Grant · GB **$617K** With 1 other
- **2024** 6 rounds
- **Dec** **[Refoxy Pharma](https://millionrounds.com/company/refoxy-pharma)** Seed · DE **$9.6M** With 1 other
- **Oct** **[Aignostics](https://millionrounds.com/company/aignostics)** Series B · DE **$34M** With 3 others
- **Aug** **[ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics)** Grant · FR **$22M** With 6 others
- **Jun** **[Tacalyx](https://millionrounds.com/company/tacalyx)** Seed · DE **$7.5M** With 2 others
- **Mar** **[Asgard Therapeutics](https://millionrounds.com/company/asgard-therapeutics)** Series A · SE **$33M** With 2 others
- **Jan** **[Acousia Therapeutics](https://millionrounds.com/company/acousia-therapeutics)** Venture · DE **Undisclosed** Sole investor
- **2023** 6 rounds
- **Dec** **[xCures](https://millionrounds.com/company/xcures)** Venture · US **Undisclosed** With 2 others
- **Oct** **[Actym Therapeutics, Inc.](https://millionrounds.com/company/actym-therapeutics-inc)** Series A · US **$26M** With 2 others
- **May** **[DiogenX](https://millionrounds.com/company/diogenx)** Series A · FR **$37M** With 2 others
- **Apr** **[T3 Pharmaceuticals](https://millionrounds.com/company/t3-pharmaceuticals)** Venture · CH **Undisclosed** With 1 other
- **Jan** **[C-mo Medical Solutions](https://millionrounds.com/company/c-mo-medical-solutions)** Seed · PT **$760K** With 1 other
- **Jan** **[Rewind Therapeutics](https://millionrounds.com/company/rewind-therapeutics)** Venture · BE **Undisclosed** Sole investor
- **2022** 4 rounds
- **Dec** **[Ruipeng Pet Healthcare](https://millionrounds.com/company/ruipeng-pet-healthcare)** Venture **Undisclosed** With 4 others
- **Aug** **[etherna immunotherapies](https://millionrounds.com/company/etherna-immunotherapies)** Series B · BE **$39M** With 3 others
- **May** **[Perfood](https://millionrounds.com/company/perfood)** Venture · DE **Undisclosed** With 1 other
- **Jan** **[Optina Diagnostics](https://millionrounds.com/company/optina-diagnostics)** Series A · CA **$2.1M** With 4 others
- **2021** 4 rounds
- **Dec** **[OncoMyx Therapeutics](https://millionrounds.com/company/oncomyx-therapeutics)** Series B · US **$50M** With 2 others
- **Jul** **[Dopavision](https://millionrounds.com/company/dopavision)** Series A · DE **$14M** With 2 others
- **May** **[Rinri Therapeutics](https://millionrounds.com/company/rinri-therapeutics)** Grant **$4.5M** With 2 others
- **Mar** **[Delonix Bioworks](https://millionrounds.com/company/delonix-bioworks)** Seed **$14M** With 2 others
- **2020** 3 rounds
- **Sept** **[Libra Therapeutics](https://millionrounds.com/company/libra-therapeutics)** Series A **$29M** Sole investor
- **Aug** **[Bodyport](https://millionrounds.com/company/bodyport)** Series A **$11M** With 4 others
- **Jan** **[NBE-Therapeutics](https://millionrounds.com/company/nbe-therapeutics)** Series C **$22M** With 1 other
- **2019** 6 rounds
- **Dec** **[ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics)** Series B · FR · FinSMEs **$53M** With 9 others
- **Dec** **[Metabomed](https://millionrounds.com/company/metabomed)** Series B **$13M** Sole investor
- **Oct** **[Abalos Technologies](https://millionrounds.com/company/abalos-technologies)** Series A · DE · FinSMEs **$13M** *Led*

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **13** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **1 in all**

**[Okairos](https://millionrounds.com/company/okairos)** Bought by [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) **$325M** May 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Pre-seed Seed Series A

Median round joined **$20M** the round, not its cheque Alone, median **$10M**

Led 5 of 59 rounds **8%**

- **Sole investor:** 7 rounds
- **Last cheque:** Sept 2026
- **Exits:** 1 from the portfolio

Rounds by stage said on their site

- Series A said *19*
- Seed said *13*
- Series B said *10*
- Venture *9*
- Series C *4*
- Grant *3*
- Pre-seed said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [KurmaPartners](https://millionrounds.com/fund/kurmapartners) 9
- [Wellington Partners](https://millionrounds.com/fund/wellington-partners) 7
- [Idinvest Partners](https://millionrounds.com/fund/idinvest-partners) 5
- [HTGF High-Tech Gründerfonds](https://millionrounds.com/fund/high-tech-grunderfonds-htgf) 4
- [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 4
- [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 3

**Pitching Boehringer Ingelheim Venture Fund?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Boehringer Ingelheim Venture Fund. A count of rooms they were both in, not a relationship either has claimed.

[**KurmaPartners** VC firm **9** rounds together](https://millionrounds.com/fund/kurmapartners)[**Wellington Partners** VC firm **7** rounds together](https://millionrounds.com/fund/wellington-partners)[**Idinvest Partners** Private equity **5** rounds together](https://millionrounds.com/fund/idinvest-partners)[**HTGF High-Tech Gründerfonds** VC firm **4** rounds together](https://millionrounds.com/fund/high-tech-grunderfonds-htgf)[**Novo Holdings** VC firm **4** rounds together](https://millionrounds.com/fund/novo-ventures)[**Forbion Capital Partners** Private equity **3** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**High-Tech Gruenderfonds** VC firm **3** rounds together](https://millionrounds.com/fund/high-tech-gruenderfonds)[**Innovate UK** VC firm **3** rounds together](https://millionrounds.com/fund/innovate-uk)[**nrw.bank** VC firm **3** rounds together](https://millionrounds.com/fund/nrw-bank)[**Bayern Kapital** Government **2** rounds together](https://millionrounds.com/fund/bayern-kapital)[**EQT Life Sciences** VC firm **2** rounds together](https://millionrounds.com/fund/eqt-life-sciences)[**Korea Investment Partners** VC firm **2** rounds together](https://millionrounds.com/fund/korea-investment-partners)

## Recently backed

The latest companies Boehringer Ingelheim Venture Fund put money into.

[**Cloverleaf Bio** $33M · Sept 2026](https://millionrounds.com/company/cloverleaf-bio)[**smartbax** Jun 2026](https://millionrounds.com/company/smartbax)[**Tacalyx** $13M · Apr 2026](https://millionrounds.com/company/tacalyx)[**TECregen** $13M · Jan 2026](https://millionrounds.com/company/tecregen)[**STRM.BIO** $8.0M · Jan 2026](https://millionrounds.com/company/strm-bio)[**Wellth** $36M · Aug 2025](https://millionrounds.com/company/wellth)

## Quick answers about Boehringer Ingelheim Venture Fund

### What does Boehringer Ingelheim Venture Fund invest in?

Boehringer Ingelheim Venture Fund invests most often at Series A and Seed (55% of the rounds on record), in sectors such as Cell Therapy, Medicine and Life-science.

### How active is Boehringer Ingelheim Venture Fund?

59 investments on record, 6 of them in the last 12 months, and it led 5. The most recent was in Sept 2026.

### What has Boehringer Ingelheim Venture Fund invested in recently?

Its most recent investments on record: Cloverleaf Bio (Seed, Sept 2026), smartbax (Venture, Jun 2026) and Tacalyx (Seed, Apr 2026).

### How big are Boehringer Ingelheim Venture Fund's cheques?

The median round it joins is $20M.

### Does Boehringer Ingelheim Venture Fund lead rounds?

Sometimes: it led 5 of its 59 investments on record (8%).

### Where does Boehringer Ingelheim Venture Fund invest?

Most of the companies it backs are in Germany (34%), the United States (19%) and the United Kingdom (9%).

### Is Boehringer Ingelheim Venture Fund investing now?

Yes: it is actively investing, with 6 investments in the last 12 months.

### Who does Boehringer Ingelheim Venture Fund invest alongside?

Most often KurmaPartners (9 rounds together), Wellington Partners (7 rounds together) and Idinvest Partners (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=boehringer-ingelheim-venture-fund) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=boehringer-ingelheim-venture-fund)